Back to Search Start Over

Kidney biopsy for the diagnosis and treatment of kidney diseases. Recommendations from the French speaking Society of Nephrology (SFNDT) and French National Authority for Health (HAS) 2022

Authors :
de Laforcade L
Bobot M
Boffa JJ
Bovy C
Cartery C
Chauveau D
Gueutin V
Isnard-Bagnis C
Jourde Chiche N
Karras A
Meftah A
Müller C
Sié P
Stehlé T
Vrigneaud L
Vuiblet V
Guerrot D
Source :
Nephrologie & therapeutique [Nephrol Ther] 2024 Feb 28; Vol. 20 (1), pp. 61-80. Date of Electronic Publication: 2024 Feb 21.
Publication Year :
2024

Abstract

Kidney Biopsy (KB) is a crucial diagnostic tool in the field of renal diseases and is routinely performed in nephrology departments. A previous survey conducted by the Société Francophone de Néphrologie Dialyse Transplantation (SFNDT) revealed significant disparities in clinical practices, sometimes conflicting with the existing literature and recently published recommendations. In response, the SFNDT wished to promote the development of best practice guidelines, under the auspices of the French National Authority for Health (HAS), to establish a standardized framework for performing kidney biopsies in France.

Details

Language :
English
ISSN :
1872-9177
Volume :
20
Issue :
1
Database :
MEDLINE
Journal :
Nephrologie & therapeutique
Publication Type :
Academic Journal
Accession number :
38379375
Full Text :
https://doi.org/10.1684/ndt.2024.68